JAGSNPHARM.BOJAGSNPHARM.BO
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$510.71M
↑ 138% above average
Average (9y)
$214.59M
Historical baseline
Range
High:$510.71M
Low:$-103.41M
CAGR
+17.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $510.71M | +57.9% |
| 2024 | $323.46M | -11.1% |
| 2023 | $363.96M | +27.9% |
| 2022 | $284.53M | +21.2% |
| 2021 | $234.72M | +114.8% |
| 2020 | $109.28M | +1.5% |
| 2019 | $107.64M | +204.1% |
| 2018 | $-103.41M | -154.3% |
| 2017 | $190.35M | +52.7% |
| 2016 | $124.66M | - |